News

RevealDx competed against 38 companies and received the award for the best poster at the Life Science Innovation Northwest Conference in Seattle in April 2023!  Life Science Innovation Northwest is part of the Life Science Washington Industry Organization.

[ MORE ]

Sirona leads a set of clinically-validated capabilities that amplifies the efficiency and precision of lung nodule assessment, improving diagnostic quality for the leading cause of cancer-related death in the United States. SAN FRANCISCO, Nov. 17, 2022 /PRNewswire/ — Sirona Medical, the leader in cloud-native radiology workflow software, today announced a comprehensive distribution and collaboration partnership with RevealDX and the integration of Sirona Medical partners with RevealDx to transform lung cancer screening with a comprehensive suite of reimbursed AI tools

[ MORE ]

The Department of Radiology and RevealDx also agreed to expand their research to evaluate RevealAI-Lung for clinical use in Lung Cancer Screening and incidentally found nodules Seattle, WA – November 9, 2022 – RevealDx announced today that their first installation of RevealAI-Lung in Europe, at the Royal United Hospitals Bath NHS Foundation Trust, has yielded Royal United Hospitals Bath NHS Foundation Trust and RevealDx Announce the Completion of an Evaluation of RevealAI-Lung on High Risk Patients

[ MORE ]

Seattle, WA RevealDx announced today that Dr. Lauren Nicola has joined the company as their CMO.   Chris Wood, CEO of RevealDx, said, “We are thrilled to have such an accomplished clinical and business leader on our team.  The appointment of Dr. Nicola as our CMO also reaffirms our belief that medical imaging AI should be RevealDx announces appointment of Lauren Nicola M.D. as Chief Medical Officer

[ MORE ]